Recent drug decriminalisation failures in Oregon and British Columbia have sparked intense debate about progressive drug policy approaches. Both jurisdictions hastily reversed their experimental programmes after experiencing dramatic increases in overdoses, public disorder, and crime. These outcomes highlight fundamental misunderstandings about Portugal’s original model.

The Portuguese Model: More Than Meets the Eye

Portugal’s 2001 drug decriminalisation policy has long been misrepresented by North American advocates. Contrary to popular belief, Portugal never permitted consequence-free drug use. Instead, the country established “dissuasion” commissions comprising doctors, social workers, and lawyers who assess apprehended drug users and impose appropriate sanctions.

These commissions wield significant arbitrator-like powers, including warnings, fines, compulsory drug education, location bans, property confiscation, and wage garnishment for non-compliance. Users receive strong encouragement to seek voluntary treatment, with most penalties waived upon acceptance. This system effectively created an alternative justice pathway that coercively diverts users into rehabilitation rather than incarceration.

The Portuguese approach also required substantial investment in addiction and mental health infrastructure, including methadone clinics, ensuring sufficient capacity to absorb diverted patients. This comprehensive framework contradicts the simplified narrative that Portugal simply removed all consequences for drug use.

Initial Success and Subsequent Decline

Portugal’s early results appeared impressive during the 2000s. Drug-related HIV infections halved, non-criminal drug seizures surged 500%, and the number of addicts in treatment increased by two-thirds. These outcomes fuelled international advocacy for similar approaches, despite mounting evidence of later deterioration.

The 2008 financial crisis marked a turning point. Austerity measures slashed public drug-treatment capacity, creating year-long waiting times for state-funded rehabilitation. Police stopped citing users for possession, believing dissuasion commissions had become dysfunctional. The government outsourced addiction services to ideological nonprofits prioritising “harm reduction” over treatment engagement.

These changes gradually transformed Portugal’s recovery-focused system into one that normalises addiction. Post-COVID developments accelerated this decline, with the 2023 overdose rate reaching a 12-year high and police chiefs reporting drug problems comparable to pre-decriminalisation levels.

Oregon’s Flawed Implementation

Oregon’s Measure 110, launched in late 2020, exemplifies decriminalisation policy mistakes that plagued North American experiments. Despite citing Portugal’s success, Oregon failed to establish meaningful coercive mechanisms for treatment diversion.

The state merely offered drug users a choice between paying $100 tickets or calling health hotlines, imposing no penalties for non-compliance. Police data from 2022 revealed that 81% of ticketed individuals simply ignored their fines, making drug possession effectively consequence-free.

Oregon compounded these errors by failing to invest in treatment capacity whilst defunding existing prevention programmes to finance unused support systems. The predictable results included nearly 50% increases in overdose deaths between 2021 and 2023, rampant public drug use, and sufficient disorder to prompt a 90-day fentanyl emergency declaration in Portland.

Facing overwhelming public backlash, Oregon terminated its experiment in spring 2024 after almost four years of demonstrable failure.

British Columbia’s Abbreviated Disaster

British Columbia’s three-year pilot project, launched in January 2023, repeated Oregon’s fundamental errors. Canadian policymakers assumed that “destigmatising” treatment would naturally increase uptake, eliminating any need for coercive tools.

Users caught with under 2.5 grams of illicit substances received cards containing local health service contacts and nothing more. This approach proved equally catastrophic, with open drug use and public disorder exploding throughout the province.

Public outrage intensified when parents discovered proliferating syringes on children’s playgrounds and learned that hospitals permitted open fentanyl and methamphetamine smoking in shared patient rooms. A 2025 JAMA Health Forum study found the pilot associated with significant spikes in opioid hospitalisations compared to other Canadian provinces.

Political pressures forced early termination in 2024, cutting the pilot short by two years as polling showed surging support for conservative opposition parties.

Critical Analysis of Drug Decriminalisation Failures

These North American experiments failed because policymakers fundamentally misunderstood Portugal’s approach. They assumed decriminalisation meant removing consequences rather than redirecting them toward therapeutic outcomes.

Effective decriminalisation requires robust alternative accountability systems that coerce treatment engagement whilst maintaining public order. The Portuguese model’s initial success depended on combining non-criminal sanctions with substantial treatment infrastructure investments. These elements were entirely absent from North American implementations.

The evidence clearly demonstrates that removing consequences without providing coercive treatment alternatives leads to normalisation of drug use rather than rehabilitation. This represents a dangerous misinterpretation of harm reduction principles that prioritises ideology over evidence-based outcomes.

Lessons for Future Policy Development

The decriminalisation policy mistakes evident in Oregon and British Columbia offer several crucial lessons for future reform efforts:

First, successful decriminalisation requires maintaining meaningful consequences that redirect users toward treatment rather than eliminating accountability entirely. Portugal’s dissuasion commissions demonstrate how non-criminal sanctions can effectively coerce therapeutic engagement.

Second, adequate treatment infrastructure must precede any policy changes. Both North American experiments failed to ensure sufficient rehabilitation capacity, making their approaches fundamentally unworkable regardless of design.

Third, public order considerations cannot be ignored. Policies that permit open drug use in public spaces predictably generate community backlash that undermines long-term reform prospects.

The Role of Treatment Coercion

Evidence increasingly supports treatment coercion as a necessary component of successful addiction policy. Voluntary treatment uptake remains insufficient to address population-level addiction problems, particularly given the decision-making impairments associated with substance use disorders.

Portugal’s model demonstrates how coercive mechanisms can effectively channel users into treatment whilst avoiding traditional criminal justice involvement. This approach recognises addiction as a health condition requiring intervention rather than a lifestyle choice deserving social acceptance.

Evidence-Based Reform

Future drug policy reform must prioritise evidence over ideology. The dramatic drug decriminalisation failures in North America demonstrate the dangers of implementing policies based on superficial understandings of successful models.

Effective reform requires comprehensive approaches that combine accountability mechanisms with robust treatment infrastructure. Simply removing criminal penalties without providing alternative consequences and pathways to recovery predictably leads to policy failure and public backlash that undermines legitimate reform efforts.

Policymakers must acknowledge that addiction represents a serious health condition requiring intervention rather than social acceptance. Successful policies should aim to normalise rehabilitation, not drug use itself.

The Portuguese experience, both its initial success and subsequent decline, offers valuable lessons about maintaining the delicate balance between compassion and accountability necessary for effective addiction policy.

Source: Break the Needle